Your surgeon may recommend finasteride or minoxidil after your hair transplant. The recommendation isn't just an upsell — there's a genuine medical rationale. But it's also a long-term prescription decision with trade-offs that most clinic pages skip.

Why native hair continues to fall after a transplant

Transplanted donor hair is DHT-resistant and permanent. Non-transplanted native hairs continue their natural genetic loss pattern.

For many patients, areas surrounding the transplanted zone keep thinning over time — potentially creating an unnatural appearance where transplanted hair becomes an isolated island in front of continuing recession.

There are two ways to address that: maintenance medication, or a conservative design that stays natural as loss progresses. A good surgeon will discuss both rather than treating medication as automatic.

What finasteride does — and what its safety warnings now say

Finasteride blocks the enzyme converting testosterone to DHT, the hormone primarily responsible for male pattern hair loss. It is the most studied oral treatment for the condition, and the original trials reported that a large majority of men stopped losing hair and a substantial proportion saw some regrowth over two years. Effects take 6–12 months to judge and stop when the drug stops.

In June 2025, after an EU-wide review, the European Medicines Agency's safety committee confirmed suicidal ideation as a side effect of finasteride tablets. The frequency is listed as unknown. Most reported cases involved the 1 mg dose — the hair-loss dose. EU product information now advises patients experiencing mood changes to seek medical advice and, on the 1 mg dose, to stop treatment.

The UK's MHRA states that finasteride is associated with depression, suicidal ideation and sexual dysfunction which may persist after treatment is stopped, advises prescribers to ask about any history of depression or suicidal ideation before prescribing, and has required patient alert cards in UK packs since 2024. UK adverse-event data to May 2025 includes 170 reports of suicidal ideation for finasteride and 19 fatal reports of suicide.

Adverse-event reports don't prove causation in each case, and millions of men take finasteride uneventfully. But the common reassurance that side effects always resolve on stopping is not what the regulators currently say.

Also worth knowing: finasteride is contraindicated in women who are or may become pregnant because it can cause abnormalities in a male fetus, and women of childbearing potential shouldn't handle crushed or broken tablets. Finasteride also roughly halves PSA levels, so anyone having prostate screening must tell the doctor ordering the test.

What minoxidil does

Minoxidil extends the hair growth phase and improves blood supply to follicles. It doesn't touch DHT, so it is generally less effective than finasteride at preventing further loss — but it carries no regulatory warning comparable to finasteride's.

Topical minoxidil is available over the counter. Low-dose oral minoxidil, originally a blood-pressure medication, is increasingly prescribed off-label; because of its cardiovascular origins it needs prescribing and monitoring by a doctor who knows your history. The most common side effect at low doses is increased fine body hair.

Topical finasteride and dutasteride

Topical finasteride is often marketed as the safer route. Systemic absorption is lower but not zero, and the FDA has issued a safety alert about compounded topical finasteride products based on adverse-event reports in which most effects continued after the product was stopped.

Dutasteride suppresses DHT more strongly and can produce stronger regrowth, but its side effects are broadly similar and potentially more pronounced, and it persists in the body for weeks rather than hours — so if problems arise, they clear far more slowly.

The honest verdict

If you're transplanted before your loss has stabilised, some form of maintenance makes clinical sense to protect the result. It is still a real decision: a long-term medication with the risk profile above, versus a conservative surgical plan designed to age well without it. Both are legitimate.

Take the question to your surgeon and a prescriber who will discuss both sides.

This is general information, not medical advice, and is not a substitute for a prescribing clinician. If you experience mood changes, depression or thoughts of self-harm while taking any medication, seek medical advice promptly. In the US, the 988 Suicide & Crisis Lifeline is available by call or text; in the UK and Ireland, Samaritans on 116 123; elsewhere, findahelpline.com lists local services. Foxpare is an information and matching service, not a medical provider.

Sources

  • European Medicines Agency. Measures to minimise risk of suicidal thoughts with finasteride and dutasteride medicines. EMA/202053/2025, August 2025 (PRAC recommendation endorsed by CMDh, June 2025).
  • MHRA. Finasteride and dutasteride – updated safety warnings for psychiatric side effects and sexual dysfunction. Drug Safety Update, 2025.
  • MHRA Yellow Card data, 1994 – 31 May 2025.
  • US FDA safety communication on compounded topical finasteride products.